Crinetics Pharmaceuticals (CRNX) Margins & Profitability 2020-2026

Gross, EBITDA, operating, and net margin trends

Margins

Profit margins across the income statement

Gross Margin: 98.1%
EBITDA Margin: -1297.0%
Op. Margin: -1307.8%
Net Margin: -1191.0%

Op. margin of -1307.8% is up 29552.3% YoY — cost efficiency is improving. Net margin at -1191.0% and gross margin of 98.1% — earnings take a bigger bite when COGS stays lean..

Gross Margin (%)

Revenue left after direct cost of goods sold

EBITDA Margin (%)

Operating profitability independent of capital structure

Operating & Net Margins (%)

How much of each dollar becomes profit